Transforming cancer treatment with precision medicine

CEO Barnaby Balmforth writes on the Cambridge Business Weekly guest blog about the barriers to comprehensive biomarker testing that prevent many patients from accessing precision cancer treatments — and how the company’s ASPYRE technology is poised to revolutionize the field of cancer treatment by breaking down those barriers.

Read on Cambridge Business Weekly